The terminal alkyne is a functionality widely used in organic synthesis, pharmaceutical science, material science, and bioorthogonal chemistry. This functionality is also found in acetylenic natural products, but the underlying biosynthetic pathways for its formation are not well understood. Here we report the characterization of the first carrier proteindependent terminal alkyne biosynthetic machinery in microbes. We further demonstrate that this enzymatic machinery can be exploited for the in situ generation and incorporation of terminal alkynes into two natural product scaffolds in E. coli. These results highlight the prospect for tagging major classes of natural products, including polyketides and polyketide/non-ribosomal peptide hybrids, using biosynthetic pathway engineering.
, but all of these reports have been limited to bioinformatics or in vivo studies through mutagenesis or heterologous expression in yeasts and plants because it is notoriously difficult to work with the membrane-bound desaturases in vitro. As a result, no definitive information on the reactions catalyzed by these enzymes is available to date. Regardless of these challenges, a thorough characterization of terminal alkyne biosynthetic machinery, particularly the substrate specificity, is the indispensable first step for utilization of these enzymes in the biosynthesis of alkyne-labeled natural products.
While the genetic basis for the synthesis of most acetylenic natural products is yet to be determined, two gene clusters have been identified to be responsible for the synthesis of jamaicamides and carmabins ( Fig. 1) , which are terminal alkyne-bearing polyketide/nonribosomal peptide (PK/NRP) hybrids from the marine cyanobacteria Moorea producens (formerly classified as Lyngbya majuscula) 18, 19 . These findings serve as a starting point for studying the enzymatic machinery involved in the biosynthesis of terminal alkynes residing in PK/NRP molecular scaffolds. It is proposed that the alkyne functionality of jamaicamide is introduced as a short-chain alkynoic starter unit by a three-gene operon: jamABC encoding a homolog of a fatty acyl-CoA ligase, a membrane-bound fatty acid desaturase, and an acyl carrier protein (ACP), respectively. A tri-gene cassette camABC highly homologous to jamABC has also been identified in the biosynthetic gene cluster of carmabins, suggesting a conserved biosynthetic logic in generating the terminal alkyne functionality in both families of compounds.
JamA particularly prefers 5-hexynoic and 5-hexenoic acid vs. other saturated fatty acids in the ATP-PP i exchange assay 18 , indicating that the JamB-mediated desaturation may occur prior to activation by JamA, on the free hexanoic acid. However, fatty acids with varying saturation levels (hexanoic, 5-hexenoic, and 5-hexynoic acid) can be loaded onto JamC upon activation by 4 
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, raising questions about the native substrate and reaction timing of JamA and JamB. The use of a free fatty acid or ligation of a C 6 starter to the ACP prior to dehydrogenation would be unexpected as membrane desaturases typically accept CoA or glycerolipid substrates 12, 21 .
Here we elucidated the functions of JamA, B, and C in the biosynthesis of terminal alkyne functionality of jamaicamide by both in vitro and in vivo analyses. JamB was demonstrated to be a carrier protein-dependent membrane-bound acetylenase/desaturase with stringent substrate specificity towards both the acyl group and the acyl carrier. The terminal alkyne biosynthetic gene cassette was further co-expressed with biosynthetic genes of two different natural products in E. coli for generating terminal alkyne-labeled PK and PK/NRP hybrid without the feeding of alkynoic precursors.
RESULTS
Reconstitution of JamABC activities in vitro
To probe the activity of JamABC in terminal alkyne formation, we overexpressed each gene in E. coli and purified JamA, JamC, and the JamB-containing membrane fraction for use in biochemical assays (Supplementary Results, Supplementary Fig. 1 ). The membrane fraction purified from the E. coli strain transformed with an empty vector was prepared in parallel and used as a negative control in JamB assays. We first tested the requirement of a thio-carrier for JamB using substrates that included 5-hexenoic acid, 5-hexenoyl-CoA, and 5-hexenoyl-JamC.
We synthesized 5-hexenoyl-CoA enzymatically using ORF35, a promiscuous acyl-CoA ligase that we recently identified 22 . 5-Hexenoyl-JamC (1) was prepared in situ using an enzymatic reaction containing JamA, JamC, and 5-hexenoic acid 20 . While JamB failed to act on 5-hexenoic acid or 5-hexenoyl-CoA ( Supplementary Fig. 2 and 3) , 5-hexenoyl-JamC was converted by JamB to 5-hexynoyl-JamC (2) as detected by liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analysis (Fig. 2, a, b and c) . Product identity was further confirmed by comparison to authentic 2 synthesized using the enzymatic reaction containing JamA, JamC, and 5-hexynoic acid 20 . Control experiments demonstrated that the formation of 2 relied on the presence of both JamB and 1. We were able to observe the activity of JamB without the addition of an electron transport system and reducing equivalents, indicating that these presumably essential components were provided at least to some extent by the partially purified JamBcontaining membrane fraction from E. coli 23 . Indeed the introduction of ferredoxin, ferredoxin reductase, and NADPH slightly increased the activity of JamB (by ~35%), suggesting that the reduced ferredoxin is a likely electron donor for the JamB-catalyzed desaturation reaction. This result is consistent with observations that in cyanobacteria, membrane-bound desaturases typically use ferredoxin instead of cytochrome b 5 as an electron transport partner [23] [24] [25] , and ferredoxin is often a required cofactor for soluble acyl-ACP desaturases 26 . We thus confirmed JamB to be the first terminal acetylenase/desaturase that functions in a microbial polyketide synthase (PKS)/non-ribosomal peptide synthetase (NRPS) pathway to install a terminal alkyne functionality. It is notable that JamB is also the first exception to the conventional view that only soluble desaturases work on acyl-ACPs while membrane desaturases utilize acyl-CoAs or lipids as substrates 12, 21, 27 .
Substrate specificity of JamB
Since bifunctional desaturases have been observed to catalyze alkyne formation from a saturated fatty acyl chain through a four-electron oxidation 12 , we first examined the activity of JamB on hexanoyl-JamC. The conversion from hexanoyl-JamC to 5-hexynoyl-JamC was undetectable; instead we observed the formation of 5-hexenoyl-JamC in a trace amount catalyzed by JamB 6 ( Supplementary Fig. 4) . We next probed the acyl chain length specificity of JamB. Alkenoyl moieties ranging in the chain length from five to eight carbons were enzymatically linked to JamC using the promiscuous JamA 18 (4-pentenoyl-JamC and 6-heptenoyl-JamC) ( Supplementary Fig. 5 and 6 ) or a phosphopantetheinyl transferase Sfp 28 (7-octenoyl-JamC) (Supplementary Fig. 7) . JamB failed to convert these alkenoyl-JamCs to their corresponding alkynoyl-JamCs ( Fig. 3 and Supplementary Fig. 5-7) , demonstrating the stringent chain length specificity of JamB. In addition, although JamA did not discriminate among fatty acid substrates with different unsaturation patterns such as 2-hexenoic, 3-hexenoic, and 4-hexenoic acid, LC-HRMS analyses of the enzymatic reaction mixtures of these hexenoyl-JamCs and JamB revealed no detectable formation of their corresponding hexynoyl-JamCs, suggesting that a terminal alkene functionality is required for JamB activity ( Fig. 3 and Supplementary Fig. 8-10 ).
In addition to the acyl moiety, we further scrutinized the ACP specificity of JamB. We purified three heterologous ACPs, including CamC (identity/similarity: 95/98%), scACP (identity/similarity: 8/15%) from Streptomyces coeruleorubidus NRRL 18370, and fsACP (identity/similarity: 10/19%) from E. coli BL21 (DE3). As JamA efficiently recognized CamC but not the other ACPs (data not shown), we synthesized the three corresponding 5-hexenoylACPs using JamA, scFadD (a medium-chain fatty acyl-ACP synthetase homolog encoded in the same operon as scACP), and Sfp, respectively. The activity of JamB was observed towards 5-hexenoyl-CamC but not the other 5-hexenoyl-ACPs ( Fig. 3 and Supplementary Fig. 11-13 ), implying strong protein-protein interactions between the acetylenase/desaturase and the dedicated ACP for terminal alkyne synthesis. Genome-mining analysis identified more than 80 gene clusters encoding homologs of jamABC across diverse bacterial genera ( Supplementary   Fig. 14) , suggesting that the carrier protein-dependent alkyne biosynthetic pathway is 7 widespread in bacteria. The functions and substrate specificities of these homologs are yet to be determined.
Engineered biosynthesis of alkyne-tagged natural products
Elucidation of the functions of JamABC in generating a thio-activated, short-chain alkynoic moiety defines a portable tri-gene cassette that can be utilized for in situ generation and incorporation of terminal alkynes into various molecular scaffolds through biosynthetic pathway engineering. To apply this newly characterized enzymatic machinery in E. coli, we first targeted the biosynthesis of terminal alkyne-bearing polyketides through starter unit engineering. We selected a type III polyketide synthase HsPKS1 from the plant Huperzia serrata to assemble polyketide backbones using malonyl-CoA extender units. HsPKS1 is able to accept a variety of starter units including aromatic and aliphatic (C 6 -C 10 ) CoA thioesters 29 , suggesting that the recognition of the 5-hexynoyl starter unit would be likely. Two plasmids encoding jamABC and hspks1, with each gene regulated by a T7 promoter, were transformed into the E. coli BAP1 strain 30 yielding the strain XZ1 (Supplementary Fig. 15 ). We omitted either jamA, B, C, or hspks1 individually to yield four control strains. The resulting strains were grown in shake flask cultures, and after induction with IPTG, the strains continued to grow in F1 minimal medium supplemented with 5-hexenoic acid at 20 C for two days. Analyses of these culture extracts by HPLC and LC-HRMS revealed the production of a putative alkyne-labeled polyketide 3 by XZ1 at ~0.3 mg/L (Fig. 4) which is comparable to the typical polyketide titer in E. coli using similar culture conditions 31 . The product 3 was later revealed to be a novel pyrone with the retention time, UV spectrum, and mass patterns precisely matching those of the standard synthesized by a scaled-up enzymatic reaction of HsPKS1 using the 5-hexynoyl starter unit (Supplementary Table 3 and Supplementary Fig. 16 and 17) . 3 was presumably formed by condensing the 5-8 hexynoyl moiety with two malonyl-CoAs followed by a spontaneous intramolecular cyclization.
It is notable that in addition to 3, a major byproduct 4 bearing a terminal alkene functionality retained from the fed alkene precursors was also produced ( Fig. 4 and Supplementary Fig. 
18)
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. 3 and 4 were made in a ~1:4 ratio; this efficiency was mostly likely dictated by the nonoptimized activity of the membrane-bound acetylenase/desaturase JamB in this heterologous host as HsPKS1 showed no preference towards 5-hexenoyl and 5-hexynoyl starter units. Omitting JamC completely abolished the production of 3 as determined by HPLC and the much more sensitive LC-HRMS analyses ( Fig. 4 and Supplementary Fig. 16 ), which further confirmed the necessity of this carrier protein for the desaturation activity of JamB. Deletion of JamA decreased the titer of 3 by ~30-fold as shown by selected MS ion monitoring ( Supplementary Fig. 16 ), indicating endogenous acyl-ACP synthetases of E. coli could complement the activity of JamA, albeit with a much lower efficiency. In addition, the reported broad substrate specificity of HsPKS1 rendered the engineered E. coli strain XZ1 an excellent reporting system for further probing the fatty acyl substrate specificity of JamB. We fed selected fatty acids, such as 4-pentenoic, 6-heptenoic, and 7-octenoic acids, to the E. coli cultures, and analyzed culture extracts by both selected MS ion monitoring and MS-based comparative metabolomics between XZ1 and negative control strains without jamB. This extensive analysis revealed that XZ1 failed to produce alkyne-tagged products using these precursors ( Supplementary Fig. 19-21) , consistent with the in vitro biochemical results showing the strict substrate specificity of JamB.
We next explored extender unit engineering, an alternative strategy for incorporating an alkynoic extender unit into the molecular scaffolds of PKs. Although the majority of PKs utilize malonyl-CoA or methylmalonyl-CoA as extender units, longer-chain fatty acyl extender units have been identified in a few modular assembly lines 33 . We recently scrutinized the biosynthetic machinery for antimycin-type depsipeptides and identified a minimum set of enzymes (AntCDEFGM) required for generation of the antimycin dilactone scaffold . In order to eliminate the requirement of alkynoic precursors and de novo biosynthesize alkyne-tagged antimycin analogues, we co-expressed antCDEFGM and jamABC in the E. coli BAP1 strain ( Supplementary Fig. 22 ), which led to the production of antimycintype depsipeptides at ~0.2 mg/L. A major alkyne-bearing antimycin analogue 5 was produced with a retention time and mass fragmentation patterns matching those of the standard synthesized through PDB (Fig. 5, Supplementary Table 4 and Supplementary Fig. 23 ). As expected, the deletion of jamB or antC completely abolished the production of 5 (Fig. 5b) . The biosynthesis of 5 suggested that 5-hexynoyl-JamC could enter E. coli fatty acid metabolic pathways for additional processing.
DISCUSSION
Despite the importance of terminal alkyne and its prevalence in synthetic compounds, the biological routes to this functionality are not well understood until now. In this study, the biochemical characterization of JamA, B, and C resulted in a sequence of chemical steps in generating the hexynoic starter unit for jamaicamides: 5-hexenoic acid is activated with ATP and loaded onto JamC by JamA, and then modified by JamB to form a terminal alkyne moiety before the priming of the PKS (Fig. 2a) . This carrier protein-dependent terminal alkyne biosynthetic mechanism is likely adopted in generating a variety of acetylenic natural products, such as polyynes, since the most recently identified polyyne biosynthetic gene clusters contain genes encoding a fatty acyl-AMP ligase and an ACP in proximity with those encoding desaturases 4, 16 .
In addition, although a terminal alkene was shown to be essential for JamB-catalyzed alkyne synthesis in the biochemical analysis and E. coli feeding studies, we could not rule out the possibility of hexanoic acid as the starting substrate for the system of JamABC in Moorea producens based on the substrate promiscuity of JamA and JamB towards the saturated acyl chain.
Desaturase enzymes have evolved independently twice: the widespread integral membrane desaturases are found in endomembrane systems in both prokaryotes and eukaryotes, whereas the soluble acyl-ACP desaturases are found in plastids of higher plants 12 . The conjugation of the substrate to an ACP prior to desaturation is unusual for a membrane-bound desaturase, and JamB has a sequence surprisingly reminiscent of a microsomal eukaryotic desaturase with 48% amino acid similarity to the Saccharomyces cerevisiae Ole1p Δ 9 -desaturase despite its prokaryote origin. Since plastids are hypothesized to be a result of an endosymbiotic event where early photosynthetic prokaryote invaded a primitive eukaryotic host 35 , the use of ACP in a prokaryotic context, although with few examples, can be explained from an evolutionary view. By analogy to soluble acyl-ACP desaturases, three conserved His boxes (HX 4 H, HX 2 HH, and QX 2 HH) are found in JamB and probably include the ligands for a diiron cluster at the catalytic site of the enzyme (Supplementary Fig. 1 ) 21, 36 . It is interesting that The characterization of JamA, B, and C enabled the de novo biosynthesis of terminal alkyne-labeled natural products through pathway engineering in absence of an alkynoic precursor. Two different strategies, starter and extender unit engineering, have been shown to be successful in labeling natural products based on the promiscuity of PKS/NRPS enzymatic machinery. Starter unit engineering could be generalized to tag polyketides and lipopeptides that naturally contain fatty acyl starter units, and extender unit engineering using jamABC, antE, and antD-AT in other modular assembly lines could lead to the site-selective introduction of a terminal alkyne into additional PKs or PK/NRP hybrids inside living cells. We have thus built a molecular toolbox that can be adapted to install a terminal alkyne functionality in a range of natural products. Although JamB appeared to have stringent substrate specificity and limited efficiency in E. coli, screening additional homologous gene cassettes from a large collection identified through genome-mining may yield new enzyme candidates with altered substrate specificities and improved efficiency in a targeted production organism (Supplementary Fig. 14) .
In summary, we have provided direct evidence for the first ACP-dependent terminal acetylenase/desaturase responsible for terminal alkyne synthesis by both in vitro and in vivo analyses. We have further demonstrated that this biosynthetic pathway can be exploited for the in situ generation and incorporation of terminal alkynes into different natural products in E. coli. In addition to directly producing orthogonally functionalized natural product analogues that can be subjected to facile chemical modification for drug screening, our work may significantly advance the field of natural product research through coupling with diverse azido analytical handles. For example, using a fluorogenic probe 37, 38 , in situ detection and quantification of natural products in producing cell cultures can be accomplished for the first time. Furthermore, since azide-alkyne click chemistry continues to serve as a powerful tool in drug discovery and chemical biology 5, 39, 40 , our findings open the door to numerous biological applications in which in situ enzymatic generation of a terminal alkyne is required or preferred.
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Additional information
Online methods
Materials. Phusion High-Fidelity PCR Master Mix (NEB) was used for PCR reactions.
Restriction enzymes were purchased from Thermo Scientific. 2-Hexenoic (purity 96%), 3-hexenoic (purity 97%), 4-hexenoic (purity 98%), 5-hexenoic (purity 99%), 5-hexynoic (purity 97%), 6-heptenoic (purity 98%) acids were purchased from Alfa Aesar. Hexanoic (purity >99.5%), 4-pentenoic (purity 97%), 4-pentynoic (purity 95%), 6-heptynoic (purity 90%), 7-octenoic (purity 97%) acids were purchased from Sigma Aldrich. 7-Octynoic acid (purity 95%) was obtained from AfferChem, Inc, NJ, USA. concentrated under vacuum, and dried to white solid using a lyophilizer. NMR spectra of 3 were recorded on a Bruker Biospin 900 MHz spectrometer with a cryoprobe in d6-dimethyl sulfoxide (d6-DMSO; Cambridge Isotope Laboratories). 4 was purified and characterized in a similar way.
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Biosynthesis of 5 in E. coli. BAP1/pACYC_antE-antM + pCDF_antD-antGF + pXZ53 + pXZ51, BAP1/pACYC_antE-antM + pCDF_antD-antGF + pXZ53 + pXZ52, BAP1/pACYC_antE-antM + pCDF_antD-antGF + pCOLADuet-1 empty vector + pXZ52 cells were grown in 500 mL of LB medium with 100 μg/mL carbenicillin, 100 μg/mL spectinomycin, 60 μg/mL kanamycin and 25 μg/mL chloramphenicol at 37 C to an OD 600 of 0.4-0.6. Subsequently, the cultures were supplemented with 0.5 mM IPTG, 1 mM anthranilic acid, and 1 mM 5-hexenoic acid. After 48 h of growth at 20 C, the culture broth and the cell pellets were separated by centrifugation. Antimycins were extracted from cell-free supernatant (500 mL) using ethyl acetate. Large-scale production, purification and characterization of standard 5. The standard was synthesized through PDB by feeding 1 mM anthranilic acid and 1 mM 7-octynoic acid into JL1 strain that contained antCDEFGM 42 . The culture condition was same as described above. 5 was extracted from cell-free supernatant using ethyl acetate. The solvent was removed by rotary evaporation and the residue was re-dissolved in methanol. 5 was purified using HPLC through an Agilent Eclipse Plus C18 column (4.6 × 100 mm) with a linear gradient of 25-95% CH 3 
